ClinicalTrials.Veeva

Menu
V

Vivida Dermatology | Flamingo Office

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JNJ-77242113
CTP-543
Abrocitinib
Rocatinlimab
ABP 501
Dupilumab
Remibrutinib
Humira®
Difamilast

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in a...

Active, not recruiting
Alopecia Areata
Drug: CTP-543

The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in pa...

Enrolling
Hidradenitis Suppurativa
Drug: Placebo 2
Drug: Placebo 1

Trial sponsors

Amgen logo
Concert Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo
Acrotech Biopharma logo
Novartis logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems